Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)”

2 trials

Showing 2 of 2 results

Not applicableLooking for participantsNCT07376486
What this trial is testing

Duodenal pulsENDO as an Early Treatment for Type 2 DM

Who this might be right for
Diabete MellitusT2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Chinese University of Hong Kong 40
Testing effectiveness (Phase 2)Study completedNCT02279407
What this trial is testing

Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients

Who this might be right for
T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
AstraZeneca 223

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation